lymphocytes and shows a biphasic induction in both cell types after mitogenic stimulation, with a first peak at 3 hours and a second and stronger induction at 44 to 72 hours. Study of the B-myb gene showed that this gene is low to undetectable in resting T or B cells and is strongly induced after mitogenic stimulation with a peak between 44 and 72 hours in both cell types. Finally, the A-myb gene shows a pattern of expression in lymphocytes different from that of c-myb and B-myb. It is expressed in resting T lymphocytes and its levels gradually decrease after mitogenic stimulation to become CTIVATION OF the c-myb gene to an oncogene A (v-myb) leads to hematopoietic neoplasms in both the chicken and the mouse.'*2 It is not yet clear whether deregulation of the levels of expression or the structural alterations commonly suffered by the proto-oncogene during activation are crucial for oncogenicity of v-myb in these animal models.' Although no gross structural rearrangements of the c-myb gene similar to those frequently observed in avian and murine leukemias have yet been described in human hematopoietic neoplasms, a role for this oncogene in the latter is not excluded. For this reason, characterization of the c-myb gene expression and regulation in normal hematopoietic cells is required to help define the function(s) of the c-myb protein and also to identify potential points of deregulation that may be present in human leukemias.
c-myb is mostly, although not exclusively, expressed in hematopoietic cells?-5 A high expression of c-myb appears to correlate with the immaturity of hematopoietic cells in human bone marrow637 and in murine or chicken tissues.3~~ However, it is unclear whether this reflects the higher proliferative rate of immature cells or their state of differentiation. Indeed, mature T lymphocytes from various species are induced to express high c-myb when stimulated to proliferate in vitro.8-" More direct evidence for the role of c-myb in cellular proliferation derives from studies using a c-myb specific antisense oligonucleotide that blocks the proliferation of hematopoietic cells or cell line^.'^.'^ However it is not excluded that in hematopoietic precursor cells the c-myb protein has an additional role other than the maintenance of their proliferation because in the chicken, the v-myb oncogene appears to maintain the transformed cells in an immature state" and high levels of c-myb can inhibit the differentiation of transfected hematopoietic murine cell lines. I6 With regard to T lymphocytes stimulated to proliferate in vitro, the variability of the reported kinetics of c-myb induction (from 6 to 48 hours after addition of the mitogenic signal8-'*) does not clarify whether c-myb is induced early during activation of the cells from GO to G1 or whether it is induced only in late G1 or S phase, and undetectable at 48 hours. It is also expressed in a subpopulation of large B lymphocytes but not in in vitro activated B cells. Neither of the three members of the myb family of genes was expressed in monocytes and granulocytes, even after functional activation of these cells. Taken together, these data bring further evidence for the role of c-myb in cellular proliferation and on the basis of the kinetics of its induction relative to thymidine uptake, we hypothesize that it may have a role during G1 progression in addition to that already documented for entry into S phase. Furthermore, our studies indicate that another member of the myb family of genes, B-myb, may also be involved in cellular proliferation, because its expression correlates with the induction of mitogenesis.
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therefore whether it has a role in G1 progression or is required for entry into S phase.
The c-myb protein is thought to perform its cellular functions by acting as a transcriptional a~tivator.'~-'~ It is a 75-to 80-Kd nuclear protein whose N-terminal region binds to a specific DNA sequence." The transcription activating function has been localized in the central part of the molecule and a negative regulatory role has been ascribed to the C-terminus." Recently, two genes have been isolated showing a high degree of homology to c-myb in the DNA-binding and negative regulatory domains. Hence, they have been called A-myb and B-myb." Their function is yet unknown but their homology to c-myb suggests they may also be transcription activators. Expression of these genes has only been studied in actively growing cell lines thus far?' Although their expression is not restricted to the hematopoietic system, they appear to be highly represented in hematopoietic cell lines. Their potential role in cellular proliferation has never been investigated.
To further substantiate and extend to hematopoietic cell types other than T lymphocytes the role of c-myb in cellular proliferation, and to investigate the potential role of the A-myb and B-myb genes in the same context, we have set out to study four different populations of mature human We report here that all three myb genes are tightly regulated and that expression of both c-myb and B-myb, but not A-myb, correlates directly with the induction of cellular proliferation in T and B lymphocytes.
MATERIALS AND METHODS
Peripheral blood b u m coats were obtained from normal volunteers. These were used for the purification of granulocytes, monocytes, and T lymphocytes. After separation on a FicollHypaque (Seromed, Berlin, Germany) gradient:' polymorphonuclear cells (PMN) were further purified by sedimentation for 30 minutes at 37°C in Haemagel (Stholl Farmaceuticals, Modena, Italy). 23 The remaining red blood cells were lysed briefly in water. Monocytes were purified from the mononuclear cell fraction by a second centrifugation through a one-step discontinuous Percoll gradient (46%) (Pharmacia Fine Chemicals, Uppsala, Sweden)?' The purity (93% to 96%) of monocyte and granulocyte preparations was verified by morphologic assessment of Giemsa-stained cytospin preparations. T lymphocytes were purified from the mononuclear cell fraction by rosetting with aminoethyl isothiouronium bromide hydrobromide-treated sheep red blood cells (AET-SRBC) and centrifugation through Ficoll-Hypaque as described previo~sly.~~ The purity of the T-cell population was ascertained routinely by rerosetting with AET-SRBC and counting the percentage of rosettes, and in some cases by staining with a pan-T monoclonal antibody by indirect immunofluorescence (T11, anti-CD2). T-cell preparations were 93% to 98% pure. For some experiments, mononuclear cells were fractionated on a one-step 46% Percoll gradient and the T cells present in the pellet further purified by performing two cycles of adherence to plastic in RPMI 1640 containing 15% fetal calf serum (FCS; Hyclone, Steril System, Logan, UT) to remove most contaminating monocytes and some B lymphocytes. The resulting population contained 93% T cells (CD2 positive), 5% to 6% B cells (CD20 positive), and 0.5% to 1% monocytes (CD14 positive).
Tonsillar B lymphocytes were purified by teasing out single cells from freshly excised tonsils and rosetting once with AET-SRBC. 24 The nonrosetting cells (E-fraction) were separated on a Ficoll gradient. They were then further fractionated on a four-step discontinuous gradient consisting of 40%, 50%, 55%, and 75% Percoll (Pharmacia, Uppsala, Sweden) as previously d e s~r i b e d .~~
The subpopulations sedimenting at the 40% to 50%, 50% to 55%, and 55% to 75% Percoll interfaces were collected separately and used for further studies.
Cells were cultured at 5 X lo6 cells/mL in RPMI 1640 medium (GIBCO, Paisley, Scotland) supplemented with glutamine and 10% FCS. In the case of monocytes and granulocytes, the medium was tested to be endotoxin-free by the Limulus Amebocyte lysate assay (Microbiological Associates, Walkersville, MD). Monocytes were stimulated with lipopolysaccharide (LPS) (Difco, Detroit, MI) at 10 kg/mL and granulocytes with phorbol myristic acetate (PMA) (Sigma, St Louis, MO) at 20 ng/mL. B lymphocytes were stimulated with 0.005% formalin-killed Staphylococcus aureus Cowan I strain bacteria (SAC) (Calbiochem Behring, La Jolla, CA). T lymphocytes from two to three donors were mixed immediately before the culture period and simultaneously stimulated with phytohaemagglutinin (PHA) (Wellcome, UK) at 1 Cells.
Cell cultures. Cells, 1 x lo6, were stained with propidium iodide according to standard procedures as described in more detail el~ewhere.~' Cytofluorometric analysis was performed on a 30L Cytofluorograph (Ortho Instruments, Westwood, MA) as described."
Cells were washed in ice-cold saline and total RNA was extracted from the cells using the guanidine hydrochloride (Merck, Darmstadt, Germany) method as described previously.36 Fifteen micrograms of RNA per lane were run in formaldehyde agarose gels in the presence of ethidium bromide. The RNA was transferred onto nitrocellulose filters (Schleicher & Schuell, Dassel, Germany) by standard blotting procedures. The gels as well as the nitrocellulose filters were photographed under UV light to check for the quantity and even transfer of RNA. Blots were baked at 80°C under vacuum for 2 hours.
The probe for the detection of c-myb was a complete human cDNA plasmid called pCM8, kindly donated by Dr R. Dalla Favera (New York University School of Medicine, New York). To obtain a probe for the A-myb gene, we amplified from RNA extracted from stimulated T lymphocytes a fragment of the A-myb cDNA including nucleotides 111 to 1559 using the polymerase chain reaction (PCR) and cloned it in the pGem3 plasmid. For the B-myb gene we amplified, by PCR, from total RNA from B lymphocytes, a B-myb fragment spanning nucleotides 131 to 1153 and cloned in pTZ18. Seventy-five percent of the A-myb and 90% of the B-myb clones were sequenced using the dideoxynucleotide chain termination method" and the sequenase enzyme (United States Biochemical Corporation, Cleveland, OH), and were found to be identical to the published sequences of these genes." Furthermore, the presence and location of at least three different restriction sites was verified for all plasmid probes used.
Plasmid probes were labeled with "P-dCTP (Amersham) by a standard nick-translation procedure to specific activities of 1 to 2 x 10' c p d p g DNA. Hybridizations were performed overnight at 42°C in 50% formamide, 1X Denhardt, 1% sodium dodecyl sulfate (SDS) 10% dextran sulfate, 5X SSC, 250 p g h L boiled salmon sperm DNA, and 0.02 mol/L phosphate buffer. Washing was done in 0.1 to 0.5X SSC (0.75 mol/L NaCI, 0.075 mol/L Na citrate), 0.1% SDS at 55°C. Filters were exposed to XAR-5 films (Kodak, Rochester, NY) with two intensifying screens for 24 to 72 hours at -70°C. Northern blots were quantified by laser densitometric scanning.
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RESULTS
Expression of A-myb, B-myb, a n d c-myb in resting and stimulated T cells. To determine the pattern of expression of t h e myb family of genes in proliferating T lymphocytes, resting T cells were purified from t h e peripheral blood of more than one donor, pooled, a n d stimulated with PHA. Proliferation was therefore a consequence of both a mixed lymphocyte reaction (MLR) and the response to PHA. Northern blots of total RNA extracted at various times after stimulation were prepared. The photographs of the ethidium bromide-stained gels as well as of the nitrocellulose filters after transfer of the RNA clearly show that the quantities of RNAs loaded and transferred were equivalent in all lanes (see Figs 1A and 3A) . The control hybridization of the same blot with an a-actin probe confirms that all lanes contained RNA, although a significant increasc in actin RNA was repeatcdly observed during proliferation of T lymphocytes (see Fig lB, lanes 2 through 6 and Fig 3B,  lanes 2 through 9) , a finding commonly observed for housekeeping genes in proliferating T cells." Hybridization with probes specific for the three members of the myh family of genes showed that each has a distinct pattern of expression in T lymphocytes. The 4.0-kb c-myh mRNA was not detectable in resting T cells (Fig lB, lane 2) but was induced after mitogenic stimulation (Fig lB, lanes 4 through  6) . In our conditions and in repeated experiments, we could observe a relatively rapid appearance in c-myh mRNA, clearly visible 3 hours after the initiation of culture (Fig lB,  lane 4) , but not at 30 minutes (Fig lB, lane 3) . In addition, the induction of c-myh was biphasic: the steady-state c-myh mRNA levels first peaked at 3 hours, decreased slightly at 36 hours, and then increased again and to high levels during the late culture period (92 hours) (Fig lB, lanes 4 through  6) . To verify that the early c-myh induction at 3 hours was not the result of our purification procedure, the experiment was repeated on a population of T lymphocytes purified by negative selection as described in Materials and Methods. In this case, cells from individual donors were stimulated with PHA. c-myh induction was also observed at 3 hours under these conditions (Fig 2B, lane 3) , thus ruling out the role of both the purification procedure and of the MLR stimulation. Finally, the effect of cycloheximide on the early c-myh induction was tested and found to be inhibitory ( Fig  2B, lane 4) .
The same blots shown in Fig 1 were then tested with the B-myh probe. We observed a B-myh mRNA of about 3.3 kb, which is in good agreement with published data.'' As for c-myh, the B-myh message was not detectable in resting cells (Fig lB, lane 2) and was induced after stimulation. However, the B-myh message, unlike c-myh, could be observed only in the late culture period (48 to 92 hours) (Fig lB, lanes 3 through 6) . An experiment that included more time points demonstrated that B-myh expression peaked between 60 and 72 hours (Fig 3B, lanes 7 and 8) .
With regard to A-myh, the expected 5-kb mRNA" was present in resting T lymphocytes (Fig 3B, lane 2) and slowly declined after mitogenic stimulation to become undctectable at 60 hours ( Fig 3B, lanes 2 through 9) . A-myh gcne expression is therefore repressed rather than induced during the induction of T lymphocytes to proliferate, unlike the c-myb and B-myh genes.
To better quantify the relative changes in expression of the c-myh, B-myh, and A-myh genes in stimulated T cells, To determine during which phase of the cell cycle the myh genes are regulated in their expression and therefore their potential function in the cycle, the incorporation of 'Hthymidine was measured in parallel to Northern analysis and is shown in Fig 4B. As expected, a peak of thymidine incorporation was observed 48 hours after the initiation of stimulation. The kinetics of entry into S phase were also studied by performing cell cycle analysis and were found to be identical to those obtained by measuring thymidine uptake (data not shown). Therefore, the first peak of c-myb c -myb mRNA precedes by at least 18 to 24 hours the initiation of DNA synthesis by the majority of the cells. However, the second and more substantial increase in c-myh more closely corresponds to entry into S phase. With regard to the B-myh gene, its induction approximately parallels DNA synthesis in these cells. Finally, downregulation of the A-myh gene expression is also a relatively late event during T-cell stimulation that in this case inversely correlates with the induction of DNA synthesis.
B -myb actin
B lymphocytes were chosen as another cell type that can be induced to strongly proliferate in vitro. Tonsils are a good source of Expression of mybgenes in tonsillar Bfiactions. B lymphocytes but contain cells at various stages of activation. Purified tonsillar B lymphocytes were therefore subfractionated according to density on a discontinuous Percoll gradientz4 (see also Materials and Methods). Three populations of B lymphocytes were collected and characterized. Scatter analysis showed that cells in the most buoyant fraction (fraction 1) were heterogeneous in size and contained the highest proportion of large, presumably activated or blast B cells. Fraction 2 consisted mostly of medium-sized B cells, whereas fraction 3 was the most homogeneous and contained 95% to 97% small B lymphocytes (Fig 5C) . That the in vivo activated, proliferating B cells sedimented in the most buoyant fractions was confirmed by cell cycle analysis. As shown in Table 1 , 30% of Table 1) . Finally, because in vivo activated B lymphocytes have a higher expression of the CD20 antigen,'x the intensity of staining with the B1 monoclonal antibody was analyzed. Indeed, the peak intensity of fluorescence was higher in fractions 1 and 2 than in fraction 3 (Table 1) . Taken together these data demonstrate that fraction 3 contained at least 90% small resting B lymphocytes and that the in vivo activated and blast B cells sedimented in the more buoyant fractions.
We next analyzed the expression of the myb genes in the various B-lymphocyte subpopulations in Northern blots, and found that all three myh genes showed the same pattern A-myb of expression in that they were most highly expressed in the buoyant fraction and least in the small dense B-cell fraction ( Fig 5B and Table 1) .
Expression of myb genes in B lymphocytes stimulated in vitro. To study myh gene expression during proliferation of a homogeneous B-cell population, the small resting Bcell fraction (fraction 3) was stimulated in vitro with the polyclonal B-cell activator SAC, and the RNA extracted at various times was analyzed in Northern blots. As for T cells, the quantities of RNA transferred to nitrocellulose were checked to be equal in all lanes by ethidium bromide staining ( Fig 6A) and hybridization with a-actin (Fig 6B) . Hybridization with the c-myb cDNA probe showed that the expression of c-myh in resting and stimulated B lympho- (Fig 6B, lane 2) and a biphasic induction of c-myh was observed after stimulation with SAC: A first peak of c-myb expression was detected repeatedly at 3 hours (Fig 6B, lane 3) ; c-myh mRNA levels then decreased between 6 and 18 hours after stimulation (Fig 6B, lanes 4 and 5) and finally increased again between 44 and 72 hours (Fig 6B, lanes 6 and 7) . Expression of the B-myh gene in resting and stimulated B lymphocytes also showed a pattern similar although not identical to that observcd in T cells. The unstimulated B cells showed a faint B-myb band ( Fig 6B, lane 2) , which rapidly became undetectable at 3 hours (Fig 6B, lane 3) . However, the B-myh gene was strongly induced during the (Fig 6B, lanes 4 through 7) . Finally, A-myb mRNA was virtually undetectable in the resting cells (Fig 6B, lane 2) and was not induced after mitogenic stimulation with SAC for up to 96 hours (Fig 6B, lanes 3 through 7 and data not shown), unlike the c-myb and B-myb genes. The Daudi cell line control expressed relatively high levels of A-myb ( Fig  6B, lane 1) .
As for T lymphocytes, the changes of c-myb and B-myb expression following SAC stimulation of small B cells were quantified by measuring the optical density of the signals from Northern blots (Fig 4C) and a thymidine uptake assay was performed in parallel (Fig 4D) . Comparison of panels C and D shows that the first peak of c-myb expression precedes the initiation of DNA synthesis by approximately 24 hours, whereas the second and stronger c-myb induction more closely parallels the uptake of thymidine. B-myb induction showed only one peak that correlated with thymidine uptake.
Expression of the myb genes in monocytes and granulocytes. To extend our study of the myb genes to other hematopoietic cell types, highly purified preparations of granulocytes and monocytes were obtained from human peripheral blood and stimulated with PMA and LPS, respectively. Under these conditions, these cells are activated to express specific cellular functions (chemotaxis, cytotoxicity, release of superoxide ion, etc) in the absence of proliferation." As done previously, RNA was extracted at various times after stimulation and analyzed in Northern blots. Neither c-myb, (Fig 7) , nor A-myb (Fig 8) could be detected in resting or stimulated monocytes and granulocytes in repeated experiments. However, c-myb and B-myb were expressed in the monocytic cell line U937 (Fig 7B, lane 1) . As a control for the efficient functional activation of the cells, we have hybridized the same blots with a probe for cfos. c-fos mRNA was detected in unstimulated monocytes and granulocytes and was transiently induced after 30 minutes' stimulation in both cell types (Fig 7B, lanes 2  through 9 and Fig 8B, lanes 2 through 8) , as previously reported in murine"' and human cells."' Finally, hybridization with the a-actin probe confirmed that all lanes contained RNA (Figs 7B and 8B) . Granulocytes stimulated for 14 hours with PMA often had reduced levels of RNA due to some RNA degradation at this time point (Fig 7A, lane 9 and Fig 8A, lane 5) . However, even long exposures (at least 1 week) of the blots did not show the presence of any of the myb genes, suggesting they are not induced by PMA in these cells even after 14 hours (data not shown).
DISCUSSION
Although previous work has indicated a role for c-myb in the differentiation of early bone marrow progenitors;'' more direct evidence suggests that it is required for cellular pr~liferation.",'~ Our data further support the latter hypothesis and add new elements to the relation between c-myb expression and proliferation. They do not exclude an additional role for the myb genes in differentiation. In this report we show that c-myb induction correlates with prolif- fos b eration and not with functional activation in four different mature hematopoietic cell types. C-myb was induced in both T and B lymphocytes after mitogenic stimulation, and this induction was biphasic with a first peak at 3 hours and a second larger induction between 60 and 96 hours that paralleled entry into S phase. The early induction at 3 hours is earlier than has been reported by Possible explanations are that total mononuclear cells or T-cell subpopulations were used in previous reports". ' ." and they were in some cases stimulated by different mitogens?" Other differences in experimental procedures may have resulted in different sensitivities in detection of the c-myb mRNA.'"," Our finding of a biphasic c-myb induction is strengthened by the fact that it was observed in both T and B cells. The fact that a first peak of c-myb can be observed 3 hours following stimulation is important because it precedes entry into S phase by at least 18 to 24 hours. Although we have used nonsynchronized populations of cells, these data suggest that c-myb may have a role at an early stage of the cell cycle, ie, in G1 progression as well as a function in later stages, that is in late G1 or S phase. Indeed, a role for c-myb in early G1 had already been hypothesised by Churilla et aIn in studies of murine T-cell clones that express c-myb following activation of the cells from GO to G1 and before entry into S phase. Finally, the early induction of c-myb, although reminiscent of that of "early competence" genes such as c-myc, was clearly distinct from the latter because c-myb was not induced after functional activation of monocytes and granulocytes, unlike c-jos, c-jun, and c-myc,' "."' .' ' and because early c-myb induction was inhibited by cycloheximide.'.'' With regard to the B-myb gene, these are the first studies of its expression in normal cells.'' The data presented suggest that the expression of B-myb, like that of c-myb, correlates with proliferation at least in mature hematopoietic cells: the B-myb gene is not expressed in resting T lymphocytes and the low expression of B-myb detected in the purified small tonsillar B-cell population is probably due to contamination with some blast B cells rather than true B-myb expression in small resting B cells, because B-myb mRNA levels correlated with the proportion of proliferating blast B cells in density-purified B-cell fractions. Furthermore, the B-myb gene was induced in both T and B lymphocytes stimulated to proliferate in vitro and the kinetics of B-myb induction quite closely paralleled the uptake of thymidine by T and B lymphocytes. On the other hand, B-myb was not detectable in monocytes and granulocytes even after functional activation. The lack of B-myb expression in monocytes and granulocytes does not simply reflect a cell type specificity of expression of this gene because B-myb is expressed in at least some proliferating myelomonocytic cell lines'" (and this report), but probably For personal use only. on October 30, 2017. by guest www.bloodjournal.org From the fact that these cells are terminally differentiated and are not induced to proliferate in vitro. Therefore, B-myb is a good candidate for being another gene involved in the regulation of proliferation.
Interestingly, expression of the third member of the myb family, A-myb, followed a pattern different from that of both c-myb and B-myb that did not simply correlate either positively or negatively with proliferation: Although A-myb was expressed in resting T lymphocytes and downregulated after mitogenic stimulation of these cells, it was not expressed in the three other populations of resting cells studied. A-myb was, on the other hand, found to be quite highly expressed in the more buoyant and larger B-cell fractions that contain in vivo activated and blast B cells, but was not induced after in vitro mitogenic stimulation of the small B cells. Because the buoyant B-cell fraction was 96% to 97% pure, the A-myb gene is likely to be expressed in some subpopulation of B lymphocytes present in this fraction rather than in some other contaminating cells. One possibility is that the cells in the buoyant fractions that express A-myb are not proliferating B cells but some other subpopulation, such as fully differentiated plasma cells that were not generated during our in vitro cultivation with SAC; the other possibility is that in vivo but not in vitro activated blast B cells express A-myb. Many differences have already been reported between in vivo and in vitro stimulated blast B cells.28 The data presented here give a basis to investigate both hypotheses further and to determine the role of A-myb in B lymphocytes.
